In Outsourcing, Genzyme Sees An Advantage

Regarding the outsourcing of biologics manufacturing, Piet Houwen of Sanofi says,“Starting from today, where I’d say the market relationship is sixty percent driven by the sellers, I believe we’ll see a change to a move in the direction of the sponsors.”

Source: Pharmaceutical Online News - March 16, 2016 Category: Pharmaceuticals Source Type: news